Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

U.S. cardiovascular company IPOs 2006-2018

Published by Matej Mikulic, Jun 10, 2020
illustrated is the total number of initial public offerings (IPOs) for R&D stage therapeutic companies active in cardiovascular diseases and disorders in the U.S. from 2006 to 2018. In 2018, two cardiovascular companies went public.

Number of initial public offerings (IPOs) for cardiovascular companies in the U.S. from 2006 to 2018*

Loading statistic...

Additional Information

© Statista 2020

Show source

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Show sources information
Show publisher information

Release date

2019

Region

United States

Survey time period

2006 to 2018

Supplementary notes

* Figures are for U.S. R&D-stage companies.
** Added from previous editions of the same report.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

IPOs in the U.S.Mergers and acquisitionsFinancial marketsGoldman SachsStock Exchanges
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu